in | |||||
NEWS | |||||
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve In this randomized trial, we compared rivaroxaban (20 mg once daily) with dose-adjusted warfarin (target international normalized ratio, 2.0 to 3.0) in ...
| |||||
Iran denies claims al-Qaeda member killed in Tehran "In order to dodge responsibility for the criminal activities of this group and other terrorist groups in the region, Washington and Tel Aviv from time to time ...
| |||||
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a ... The ALPHEUS study, a phase 3b, randomised, open-label trial, was done at 49 hospitals in France and Czech Republic. Patients with stable coronary ...
| |||||
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
No comments:
Post a Comment